Abstract:Parenchymal leiomyomas of the breast are extremely rare, with only 25 cases reported in the literature. We report the 26th case of parenchymal leiomyoma of the breast in a 63-year-old woman who presented to us with a right breast tumor detected on her screening mammography. This tumor was evaluated by mammography, ultrasonography, and MR imaging. To the best of our knowledge, this is the first case of a parenchymal leiomyoma of the breast examined by MR imaging. MR imaging revealed an oval mass with circumscri… Show more
“…Smooth muscle is
a component that can be present in other lesions, such as fibroadenomas and hamartomas. Leiomyomas located in the parenchyma (as in the case reported here) are circumscribed
and 1.0-14.0 cm in diameter (1,2) .…”
mentioning
confidence: 57%
“…Leiomyoma of the breast originates
from the stroma of the gland and is extremely rare (2) . Mammography and ultrasound studies are commonly used as
screening tools.…”
“…Smooth muscle is
a component that can be present in other lesions, such as fibroadenomas and hamartomas. Leiomyomas located in the parenchyma (as in the case reported here) are circumscribed
and 1.0-14.0 cm in diameter (1,2) .…”
mentioning
confidence: 57%
“…Leiomyoma of the breast originates
from the stroma of the gland and is extremely rare (2) . Mammography and ultrasound studies are commonly used as
screening tools.…”
“…In patients with a confirmed diagnosis of breast leiomyoma, no cases of local recurrence have been reported to date. [11][12][13][14][15][16][17][18][19][22][23][24][25][26][27] We reviewed the literature in MEDLINE and Lilacs using the English keywords "leiomyoma", "fibroid tumors", "benign tumor", "benign neoplasms", "breast tumor", "breast neoplasms" and "ultrasonography". We found 30 case reports that described patients with leiomyoma in the breast parenchyma ( Table 2).…”
Section: Mmg = Mammogram Us = Ultrasonographymentioning
confidence: 99%
“…12-14 Mammographic images have been described as showing an isodense or hyperdense oval mass, with outlines that are most often circumscribed (Table 1). 1,13,[15][16][17][18][19][20][21] Microcalcifications relating to leiomyoma have never been described. 15,16,22,23 The effectiveness of mammography is limited in relation to lesions measuring less than 1.0 cm and breasts with predominant glands.…”
mentioning
confidence: 99%
“…They pointed out that presence of degeneration can influence the signal pattern in different sequences, as noted in leiomyoma in other regions of the body. 16 The differential diagnosis should be done in relation to lesions that have smooth muscle proliferation in the absence of epithelial or ductal structures. In this context, the lesions that comprise the differential diagnosis are angioleiomyoma, fibroadenoma and malignant phyllodes tumor.…”
INTRODUCTION: Benign tumors are often seen in breast screening examinations. However, the differential diagnosis is not always simple because of radiological similarity between the different benign lesions. CASE REPORT: We present a rare case report of leiomyoma of the breast parenchyma in a 68-year-old asymptomatic patient. The mammographic and ultrasonographic findings were similar to those observed in benign lesions. CONCLUSION: The histopathological diagnosis requires careful differentiation from lesions that have smooth muscle proliferation, especially leiomyosarcoma. The most commonly performed treatment is resection of the lesion with free margins. Although breast leiomyoma is rare, it should be considered among the differential diagnoses for breast nodules of benign appearance. Resection with safety margins proved to be the only treatment needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.